A
AINovo Biotech leverages artificial intelligence and machine learning algorithms to analyze large biomedical datasets for drug discovery. The company designs and optimizes novel biologic therapeutics, including antibodies, across focus areas like immuno-oncology and infectious diseases. Their platform accelerates R&D by enabling data-driven insights for developing next-generation biologics.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- AINovo Biotech leverages artificial intelligence and machine learning algorithms to analyze large biomedical datasets for drug discovery. The company designs and optimizes novel biologic therapeutics, including antibodies, across focus areas like immuno-oncology and infectious diseases. Their platform accelerates R&D by enabling data-driven insights for developing next-generation biologics.